Microbiome News
Microbiome Watch: What Mattered This Week May 23-31, 2026
Recently published · William DePaolo, PhD
1. A microbiome therapy for ulcerative colitis gets FDA Fast Track attention MRM Health’s lead microbiome-based therapeutic candidate, MH002, received FDA Fast Track designation for mild-to-moderate ulcerative colitis. That matters because it shows continued r...
Read article →